MK-1966 is a humanized monoclonal antibody inhibitor targeting interleukin-10 (IL-10). It blocks IL-10s suppressive effects on immune cells such as macrophages and dendritic cells, thereby restoring antitumor immune responses. MK-1966 shows promise for cancer research.
Target:
Interleukin
* VAT and and shipping costs not included. Errors and price changes excepted
